Advancements in Type 2 Diabetes Treatment: A Promising Biotech Solution
Biotech company Fractyl has developed a gene therapy for type 2 diabetes that could potentially offer a one-time treatment. The therapy involves delivering the treatment directly to the pancreas through an endoscopic procedure. Initial tests on pigs showed successful delivery of the gene therapy without adverse side effects. However, experts remain skeptical about the safety of injecting the therapy directly into the human pancreas. If proven safe and effective, this gene therapy could revolutionize the management of diabetes and weight control.